Camilla Fowst Selected Research

Hodgkin Disease (Hodgkin's Disease)

1/2021

Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Camilla Fowst Research Topics

Disease

9	Neoplasms (Cancer) 01/2020 - 08/2003
4	Neutropenia 01/2015 - 08/2003
2	Fatigue 01/2021 - 01/2015
2	Disease Progression 01/2020 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2009
1	Nausea 01/2021
1	Exanthema (Rash) 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	Body Weight (Weight, Body) 01/2019
1	Hypertension (High Blood Pressure) 01/2018
1	Proteinuria 01/2018
1	Back Pain (Backache) 01/2015
1	Pulmonary Embolism 01/2015
1	Left Ventricular Dysfunction 10/2011
1	Febrile Neutropenia 10/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2011
1	Sepsis (Septicemia) 07/2011
1	Retinoblastoma (Glioblastoma, Retinal) 01/2009
1	Sarcoma (Soft Tissue Sarcoma) 01/2007
1	Turcot syndrome 01/2004

Drug/Important Bio-Agent (IBA)

4	avelumabIBA 01/2021 - 01/2018
4	brostallicinIBA 01/2007 - 08/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 08/2003
2	B7-H1 AntigenIBA 01/2021 - 01/2019
2	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 07/2011
2	LigandsIBA 01/2020 - 01/2018
2	Axitinib (AG 013736)IBA 01/2019 - 01/2018
2	palbociclibIBA 01/2015 - 01/2009
1	Gemcitabine FDA Link 01/2020
1	PlatinumIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Sunitinib (Sutent)FDA Link 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Amylases FDA Link 01/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2015
1	Letrozole (Femara)FDA LinkGeneric 01/2015
1	Cyclin-Dependent Kinase 4IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2015
1	Cyclin D1IBA 01/2015
1	TransferasesIBA 10/2011
1	Aspartic Acid (Aspartate)FDA Link 10/2011
1	ProMune (CpG 7909)IBA 07/2011
1	OligodeoxyribonucleotidesIBA 07/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2011
1	Toll-Like Receptor 9IBA 07/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2011
1	Phosphotransferases (Kinase)IBA 01/2009
1	Phenobarbital (Luminal)FDA Link 01/2009
1	Estrogen ReceptorsIBA 01/2009
1	Cyclin DIBA 01/2009
1	stallimycinIBA 01/2004
1	Topoisomerase I InhibitorsIBA 01/2004
1	Alkylating AgentsIBA 01/2004

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2007
2	Drug Therapy (Chemotherapy) 01/2020 - 07/2011